Cargando…

Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease

BACKGROUND: Myeloperoxidase (MPO) impairing endothelial functions. We investigated whether increasing concentration of myeloperoxidase (MPO) and inflammatory markers induce progression and incident acute coronary syndrome (ACS) in stable coronary artery disease (SCAD) patients. Therefore, the concen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimak, Elżbieta, Zięba, Bartosz, Duma, Dariusz, Solski, Janusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885314/ https://www.ncbi.nlm.nih.gov/pubmed/29618370 http://dx.doi.org/10.1186/s12944-018-0718-4

Ejemplares similares

Association Between Lipids, Lipoproteins Composition of HDL Particles and Triglyceride-Rich Lipoproteins, and LCAT and CETP Activity in Post-renal Transplant Patients
por: Kimak, Elżbieta, et al.
Publicado: (2013)

Lipids and lipoproteins and inflammatory markers in patients with chronic apical periodontitis
por: Kimak, Aleksandra, et al.
Publicado: (2015)

SUN-668 Elevated Osmolal Gap in Long-Term Complication of Type 2 Diabetes
por: Klimek, Monika, et al.
Publicado: (2020)

Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies
por: Delporte, Cédric, et al.
Publicado: (2013)

Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina
por: Baseri, Mehdi, et al.
Publicado: (2014)

Mass Spectrometry for the Monitoring of Lipoprotein Oxidations by Myeloperoxidase in Cardiovascular Diseases
por: Coremans, Catherine, et al.
Publicado: (2021)

Significance of Inflammatory Markers in Diabetic Patients with Stable Coronary Artery Disease
por: Lee, Hyo-Jin, et al.
Publicado: (2009)

Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein
por: Kameda, Takahiro, et al.
Publicado: (2015)

Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
por: Abdo, Adrian I., et al.
Publicado: (2017)

The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
por: Xu, Weifeng, et al.
Publicado: (2020)

Impact of myeloperoxidase dosage in acute coronary syndrome
por: Esporcatte, R, et al.
Publicado: (2005)

Myeloperoxidase polymorphism and coronary artery disease risk: A meta-analysis
por: Wang, Yan, et al.
Publicado: (2017)

Fractional Flow Reserve Is Not Associated with Inflammatory Markers in Patients with Stable Coronary Artery Disease
por: Sels, Jan-Willem E. M., et al.
Publicado: (2012)

Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease
por: Krychtiuk, Konstantin A., et al.
Publicado: (2014)

Myeloperoxidase gene-463G > A polymorphism and premature coronary artery disease
por: Zhong, Chen, et al.
Publicado: (2009)

The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture
por: Teng, Nathaniel, et al.
Publicado: (2016)

Visceral Adiposity in Relation to Body Adiposity and Nutritional Status in Elderly Patients with Stable Coronary Artery Disease
por: Hudzik, Bartosz, et al.
Publicado: (2021)

Monstrous pulmonary artery aneurism threatens the left coronary artery
por: Sabiniewicz, Robert, et al.
Publicado: (2020)

The Effect of Untraditional Lipid Parameters in the Development of Coronary Artery Disease: Atherogenic Index of Plasma, Atherogenic Coefficient and Lipoprotein Combined Index
por: Çelik, Ersin, et al.
Publicado: (2021)

The Lipid Parameters and Lipoprotein(a) Excess in Hashimoto Thyroiditis
por: Yetkin, D. O., et al.
Publicado: (2015)

Qualitative Distinction of Autotrophic and Heterotrophic Processes at the Leaf Level by Means of Triple Stable Isotope (C–O–H) Patterns
por: Kimak, Adam, et al.
Publicado: (2015)

Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014)

Fecal Myeloperoxidase as a Biomarker for Inflammatory Bowel Disease
por: Hansberry, David R, et al.
Publicado: (2017)

Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease
por: MAYYAS, FADIA A., et al.
Publicado: (2014)

Correlation of Oxidative Stress Parameters and Inflammatory Markers in Tunisian Coronary Artery Disease Patients
por: Dandana, Azza, et al.
Publicado: (2011)

Systemic Inflammatory Markers Are Closely Associated with Atherogenic Lipoprotein Subfractions in Patients Undergoing Coronary Angiography
por: Zhang, Yan, et al.
Publicado: (2015)

Myeloperoxidase as a Marker to Differentiate Mouse Monocyte/Macrophage Subsets
por: Gurski, Cody J., et al.
Publicado: (2022)

Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients
por: Carnuta, Mihaela G., et al.
Publicado: (2017)

Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease
por: Gao, Jie, et al.
Publicado: (2022)

Neutrophil-Derived Myeloperoxidase Aggravates Non-Alcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Deficient Mice
por: Rensen, Sander S., et al.
Publicado: (2012)

Data on myeloperoxidase-oxidized low-density lipoproteins stimulation of cells to induce release of resolvin-D1
por: Dufour, Damien, et al.
Publicado: (2018)

Association of Plasma Myeloperoxidase Level with Risk of Coronary Artery Disease in Patients with Type 2 Diabetes
por: Song, Ping, et al.
Publicado: (2015)

Myeloperoxidase level around dental implants as an indicator of an inflammatory process
por: Durrani, Farhan, et al.
Publicado: (2015)

The Enzymatic and Non-Enzymatic Function of Myeloperoxidase (MPO) in Inflammatory Communication
por: Kargapolova, Yulia, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
por: Mourouzis, Konstantinos, et al.
Publicado: (2021)

Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
por: Zhou, Boda, et al.
Publicado: (2017)

Mean platelet volume is associated with serum 25-hydroxyvitamin D concentrations in patients with stable coronary artery disease
por: Korzonek-Szlacheta, Ilona, et al.
Publicado: (2018)

Myeloperoxidase in Health and Disease
por: Ortiz-Cerda, Tamara, et al.
Publicado: (2023)

Myeloperoxidase Is Not Useful for Detecting Stress Inducible Myocardial Ischemia but May Be Indicative of the Severity of Coronary Artery Disease
por: Schuhmann, Christoph G., et al.
Publicado: (2014)

LPA Genotypes and Haplotypes Are Associated with Lipoprotein(a) Levels but Not Arterial Wall Properties in Stable Post-Coronary Event Patients with Very High Lipoprotein(a) Levels
por: Rehberger Likozar, Andreja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ssg2ehjtbclsuqpjrj5snjun3f